Previous studies show that angiotensin II (Ang II) increases phosphoinositide turnover in cultured neonatal heart cells. Ang II has also been shown to transiently increase spontaneous beating behavior in these cells. In this study we seek to identify the molecular mechanism underlying this rapid (3-5-minute) 
Angiotensin-Induced Desensitization of the Phosphoinositide Pathway in Cardiac Cells
Occurs D esensitization, or loss in responsiveness, is an adaptive process displayed by many cells when exposed to a variety of external stimuli or agonists. Agonist-induced desensitization represents an important regulatory mechanism in many tissues. For example, persistent activation of the fl-receptor in cardiac muscle results in a desensitization of the cAMP response.1 This change in the cardiac responsiveness significantly limits the opportunity to pharmacologically regulate cAMP in desensitized heart tissue. Although the molecular mechanisms underlying desensitization of many agonist-activated signal transduction systems are poorly understood, specific pathways have been identified in the uncoupling of the /32-adrenergic-
The basis for the present study arises from our initial results indicating that persistent stimulation of Ang II receptors leads to a functional desensitization of cardiac cells. The focus of this study was to determine if the underlying molecular mechanism of this desensitization involved Ang II receptors or whether postreceptor components were altered.
Materials and Methods

Materials
The following substances were obtained from Sigma Chemical Co., St. Louis, Mo.: Dulbecco's modified Eagle's medium (DMEM), DMEM-HEPES, formic acid, ammonium formate, phenylephrine, and 12-O-tetradecanoylphorbol 13 
Tissue Culture
Primary cultures of neonatal rat cardiac ventricular myocytes were prepared from 1-day-old Sprague-Dawley rats as previously described.13 After dissociation of the tissue, the cells were seeded in four-well plastic tissue culture dishes (1.7-cm wells) with growth medium (DMEM, 10% fetal calf serum, 1% penicillin, and 1% streptomycin). The cells were maintained in a humidified atmosphere of 92.5% air-7.5% CO2.
Measurement of Contractile Properties
The contraction of a single cell in a spontaneously beating multicellular network was measured using an optical-video motion detection system as previously described. 5 Briefly, the four-well culture dish was mounted on the stage of an inverted phase microscope, and the cells in a single well were superfused at 1 ml/min with DMEM-HEPES plus any additional agents as indicated in "Results." The superfusion medium was equilibrated with 95% 02-5% CO2 and maintained at 32°C. The image of the beating cells was monitored using a video camera (Cohu, San Diego, Calif.), and the video signal was recorded on tape. The motion of the cell wall was measured with the use of a video dimension analyzer (Instrumentation for Physiology & Medicine, Inc., San Diego, Calif.). The video dimension analyzer provides an analog output proportional to the position of the edge of the moving cell. The contraction and relaxation velocities were obtained by electronically differentiating the analog position versus the time output of the video dimension analyzer as described previously.5 TPA was added to the superfusion buffers from stock solutions in dimethyl sulfoxide, such that the medium contained a final dimethyl sulfoxide concentration of 0.1%. Control experiments indicated that this concentration of vehicle had no effect on contractile behavior.
Measurement of Inositol Phosphates
Cells in culture (4-5 days old) were labeled with 10 ,uCi/ml [3H]inositol for 48 hours in serum-free DMEM-HEPES, 0.25% bovine serum albumin, unless otherwise indicated. Pilot studies revealed that the absence of serum during the labeling phase had no qualitative effects on the biochemical or biological responses reported in "Results." However, serumfree medium greatly improved the signal in the assay. At the time of the experiment, the cells were washed with 4x0.5 ml DMEM-HEPES and treated as indicated in "Results." The reaction was stopped by aspirating the reaction solution and rapidly adding 0.5 ml of 6% perchloric acid at 0°C. The acid extract was neutralized, and the [3H]inositol phosphates were resolved using ion-exchange chromatography as described previously. Figure 2 is that the level of the 3H-labeled lipid precursor, phosphatidylinositol, is limiting at 4 minutes. Phenylephrine was used as a probe to explore this possibility, since it had been previously reported that such a-adrenergic agonists also stimulated phosphoinositide hydrolysis in heart cells.17 As shown in the time-course curve in Figure 4 Figure 7A ). Consistent with the biochemical responses in Figure 4 , the functional responses did not desensitize to continued a-adrenergic stimulation. As shown in Figure 7B , results obtained by the use of agents that act at discrete steps in the phosphoinositide pathway support the view that the control of Ang II desensitization occurs at a step upstream from protein kinase C, phospholipase C, and G proteins.
A tentative hypothesis was that protein kinase C mediates Ang II-evoked desensitization, since this enzyme has been reported to play a role in agonistevoked desensitization of the phosphoinositide pathway in a number of other systems. 11, 19, 20 To test this hypothesis, the Ang II intracellular signaling path was shunted by directly activating protein kinase C with the phorbol ester TPA. TPA treatment (100 nM, 10 minutes) has been shown to evoke contractile responses, increase protein phosphorylation,15 and lead to a translocation of protein kinase C activity from the cytosol to the particulate fraction of cultured myocytes (data not shown). As shown in Figure   8 , TPA treatment mimicked the effects of Ang II in desensitizing the cells to the peptide. Although these data suggested that protein kinase C is an important mediator of the Ang II-evoked desensitization of myocardial cells, further studies demonstrated important differences between the Ang II and the TPA effects. In particular, TPA treatment resulted in cells that were not only desensitized to Ang II, but were also desensitized to phenylephrine stimulation (Figure 8) . The phosphoinositide response observed by direct G protein activation with A1F4 was not altered by TPA (Figure 8 ). This last result suggested that the action of TPA was like Ang II in that it altered a step in the signaling path that precedes G proteins. However, protein kinase C activation evoked a more complex pattern of desensitization compared with the peptide.
A likely hypothesis from the results in Figure 8 was that the Ang II mechanism involves molecular pro- PREI the cells to subsequent Ang II application, whereas the phosphoinositide pathway in these cells was desensitized after an Ang II pretreatment (100 nM, 10 minutes) in the normal manner (compare with Figure 9B ). Figure 9B shows expected results from control cultures (grown in parallel with the protein kinase C-depleted cells) in which pretreatment with either Ang 11 (100 nM) or TPA (100 nM) yielded cells in which the phosphoinositide pathway was desensitized to a subsequent 30-second Ang II application. Thus, Ang Il-evoked desensitization occurred in cells that were protein kinase C deficient. One factor that limited interpretations in these experiments was that Ang II receptor-effector coupling had been assessed in 30-second intervals. Significant alterations in the time course of Ang LIevoked inositol phosphate accumulation may have also explained the results of Figure 9 . Accordingly, time-course studies from 30 seconds to 5 minutes were performed ( Figure 10 ). As expected, there was no measurable Ang Il-evoked [3H]inositol phosphate accumulation for 5 minutes after short-term treatment with phorbol. In protein kinase C-depleted cells, there is a slight enhancement in the initial rate of [3H]inositol phosphate accumulation, yet desensitization, with a time course comparable to that of control cells, is still observed. These results confirmed that hormone-induced desensitization still occurred in protein kinase C-depleted cells.
Discussion
The present study examines the biochemical basis of Ang lI-induced biological desensitization in heart muscle and the role of the phosphoinositide signaling system in this process. Cultured cardiac cells were used The combined biochemical/functional approach was useful in clearly defining a selective action for Ang II. Both functional and biochemical responses to the a-agonist phenylephrine were normal in Ang IIdesensitized cells. A comparable agonist-specific desensitization of the f3-adrenergic receptor/adenylate cyclase system has been well documented and has been termed "homologous."23 In the /8-adrenergic system, receptor sequestration is not the underlying molecular mechanism of rapid, homologous desensitization.2 In the present study, the evidence derived from surface receptor measurements and blockers of receptor sequestration suggest that Ang II receptor transport from the cell surface is not a likely mechanism as well. Although Ang II receptor internalization may be important in some systems, such as vascular smooth muscle,9 the rapid, homologous desensitization of Ang II in heart appears similar to that reported for the ,B-adrenergic system.2 However, since the focus in the present studies was to examine rapid changes, it is possible that long-term receptor downregulation or sequestration may occur in heart cells. Which Step in the Phosphoinositide Path Is Altered During Desensitization?
Signal transduction systems can desensitize if any critical step in the pathway is unresponsive or blocked. Thus, a major question arises in this study: Is the Ang II-evoked homologous desensitization a result of specific changes in receptor function, as seen in the 8-adrenergic system, or a result of other crucial changes downstream in the pathway? Accordingly, the major components of the Ang II pathway, receptors, G proteins, phospholipase C, and protein kinase C, were examined in a systematic manner in a series of experiments. Although it is not possible to completely exclude the possibility that there are minor, Ang lI-sensitive compartments of G proteins, phospholipase C, or PtDIns(4,5)P2, it is most reasonable to conclude from these studies that the Ang II receptor is the locus for the rapid, homologous desensitization. Role of Protein Kinase C in Desensitization
It is evident that activation of cardiac protein kinase C can lead to an uncoupling of hormone receptors from the phosphoinositide pathway. This might be expected, since it has been well established in many systems that pharmacological activation of protein kinase C with phorbol esters results in the inhibition of agonist-stimulated PtdIns(4,5)P2 hydrolysis. 11 19,20 In the present study, short-term phorbol ester treatment resulted in a complex pattern of desensitization of the phosphoinositide path, with cells unresponsive to phenylephrine as well as to Ang II. Such a complex pattern in which cells are desensitized to multiple agonists has been previously defined as "heterologous" in the ,B-adrenergic/adenylate cyclase system.23 It is likely that the effects of phorbol are mediated by protein kinase C, since TPA treatment failed to desensitize protein kinase C-depleted cells. The target for phorbol action in the pathway is likely to be upstream from G proteins or phospholipase C, perhaps at the level of the receptors, since A1F4 -stimulated response was not attenuated in these cells. The fact that the a1-adrenergic receptor has been reported to be a substrate for protein kinase C is consistent with this model. 24 Thus, there are similarities between the Ang II system in heart and the ,B-adrenergic pathway in other tissues. In the latter system, activation of protein kinase A leads to heterologous desensitization, whereas receptor activation by agonist leads to a homologous pattern of desensitization.225
A likely hypothesis might be that Ang Il-evoked desensitization is mediated by protein kinase C. However, more detailed studies reported here indicate that this enzyme is not required for this process. The homologous pattern of hormone-evoked desensitization is very different from the heterologous one observed for phorbol ester. Further, protein kinase C-depleted cells are desensitized to Ang II in a manner analogous to that seen for normal cultures. In all, these results support the view that, although exogenous agents that activate protein kinase C can desensitize the phosphoinositide pathway, this signaling process is not promoted by agonist occupancy of the Ang II receptor. It is not possible to completely exclude the possibility that there is a small, specific pool of protein kinase C that is insensitive to phorbols and that can be recruited by Ang II stimulation.
The results with al-adrenergic agonists, which are very efficient activators of PtdIns(4,5)P2 hydrolysis, and presumably stimulate protein kinase C, make this interpretation unlikely. These agonists fail to desensitize cardiocytes at either the biochemical or functional level.
In summary, application of Ang II to heart cells leads to a rapid homologous functional/biochemical desensitization. Although receptor sequestration is not an important mechanism, the locus of the desensitization is likely to be the Ang II receptor. The characteristics of this desensitization are similar to those seen with the ,B-adrenergic pathway. Since the importance of receptor phosphorylation is well documented in that system,25 it will be of interest to directly assess the importance of phosphorylation of the Ang II receptor in this process.
